Prognostic importance of subdividing clinically staged IIIa and IIIb patients with non-small-cell lung cancer

J Clin Oncol. 1991 Feb;9(2):357-9. doi: 10.1200/JCO.1991.9.2.357.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Carcinoma, Non-Small-Cell Lung / mortality
  • Carcinoma, Non-Small-Cell Lung / pathology*
  • Combined Modality Therapy
  • Female
  • Humans
  • Lung Neoplasms / mortality
  • Lung Neoplasms / pathology*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Survival Rate